NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 55 filers reported holding NUVALENT INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,975,131 | +38.5% | 64,719 | +27.1% | 0.00% | – |
| Q2 2023 | $2,148,055 | -1.2% | 50,938 | -38.9% | 0.00% | – |
| Q1 2023 | $2,173,532 | +16.1% | 83,309 | +32.5% | 0.00% | – |
| Q4 2022 | $1,872,685 | +197.3% | 62,884 | +94.1% | 0.00% | – |
| Q3 2022 | $630,000 | +86.4% | 32,404 | +30.2% | 0.00% | – |
| Q2 2022 | $338,000 | -46.1% | 24,894 | -44.9% | 0.00% | – |
| Q1 2022 | $627,000 | -5.3% | 45,191 | +30.1% | 0.00% | – |
| Q4 2021 | $662,000 | +5918.2% | 34,746 | +7277.1% | 0.00% | – |
| Q3 2021 | $11,000 | – | 471 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $918,987,373 | 20.25% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $164,446,964 | 18.39% |
| Fairmount Funds Management LLC | 2,451,819 | $112,710,119 | 13.56% |
| Paradigm Biocapital Advisors LP | 1,638,147 | $75,305,618 | 5.11% |
| COMMODORE CAPITAL LP | 828,778 | $38,098,925 | 4.45% |
| Perceptive Advisors | 2,463,451 | $113,244,842 | 3.78% |
| Boxer Capital, LLC | 1,210,192 | $55,632,526 | 2.96% |
| Tri Locum Partners LP | 113,528 | $5,218,882 | 1.67% |
| Ikarian Capital, LLC | 278,034 | $12,781,224 | 1.54% |
| Ikarian Capital, LLC | 2,395 | $11,009,815 | 1.32% |